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Calendula officinalis Linn. (Asteraceae) is used medicinally in Europe, China and India amongst several 
places in the world. It is also known as “African marigold” and has been a subject of several chemical 
and pharmacological studies. It is used in traditional medicine, especially for wound healing, jaundice, 
blood purification, and as an antispasmodic. Chemical studies have underlined the presence of various 
classes of compounds, the main being triterpenoids, flavonoids, coumarines, quinones, volatile oil, 
carotenoids and amino acids. The extract of this plant as well as pure compounds isolated from it, have 
been demonstrated to possess multiple pharmacological activities such as anti-HIV, cytotoxic, anti-
inflammatory, hepatoprotective, spasmolytic and spasmogenic, amongst others. In this review, we have 
explored the phytochemistry and pharmacological activities of C. officinalis in order to collate existing 
information on this plant as well as highlight its multi-activity properties as a medicinal agent. This is as a 
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INTRODUCTION 
 
India is called the botanical garden of the 
world for its rich natural resources. Over 
6,000 plants in India are used in traditional, 
folklore and herbal medicine[1]. The Indian 
system of medicine has identified 1500 
medicinal plants of which 500 are commonly 
used[1]. Calendula officinalis Linn. is used 
medicinally in Europe, China, US and India. It 
belongs to the family, Asteraceae, and is 
commonly known as  Zergul (Hindi), African 
marigold, Calendula, Common Marigold, 
Garden Marigold, Marigold, Pot Marigold 
(English), Butterblume (German), Chin Chan 





The plant is classified as shown in Table 1. 
 







The plant is native to Central and Southern 
Europe, Western Asia and the US [5]. 
 
Botanical description 
Flower and fruit 
 
On the tip of each stem, there is a 5 to 7 cm 
composite flower head, as shown in Fig 1, 
consisting of an epicalyx of numerous 
narrow-lanceolate sepals, which are densely 
covered on both sides with glandular hairs. 
The inner section of the flower head is made 
up of orange-yellow tubular florets. The disc 
florets are pseudohermaphrodites but the 
female is sterile. The zygomorphic ray florets 
at the edge are female, their stamens are 
completely absent, and their inferior ovaries 
are much more developed than those of the 
tubular florets. The fruit forms only in the 
female ray flowers. The heterocarp achenes 
are sickle-shaped, curved and ringed. 
 
Leaf, stem and root 
 
The plant is an annual, seldom biennial. It 
grows to between 30 and 50 cm high, and 
has about 20 cm long tap root and numerous 
thin, secondary roots. The stem is erect, 
angular, downy and branched from the base 
up or higher. The alternate leaves are almost 
spatulate at the base, oblong to lanceolate 
above and are all tomentosae[5-7]. 
 
   
Leaves with stem               Flower 
 




In Europe, the leaves are considered 
resolvent and diaphoretic while the flowers 
are used as a stimulant, antispasmodic and 
emmenagogue[2]. In England, the decoction 
of the flowers was used as a posset drink for 
the treatment of measles and smallpox, and 
the fresh juice as a remedy for jaundice, 
costiveness (constipation) and suppression of 
menstrual flow [8]. In India, the florets are 
used in ointments for treating wounds, 
herpes, ulcers, frostbite, skin damage, scars 
and blood purification. The leaves, in 





Subkingdom Tracheobionta  
 Division Magnoliophyta 
Class Magnoliopsida 





Species C. officinalis 
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PHYTOCHEMISTRY 
 
A number of phytochemical studies have 
demonstrated the presence of several 
classes of chemical compounds, the main 
ones being terpenoids, flavonoids, 
coumarines, quinones, volatile oil, 




Various terpenoids (Table 2) have been 
reported from the petroleum ether extract of 
C.officinalis flowers. They include sitosterols, 
stigmasterols[9], diesters of diols[10], 3-
monoesters of taraxasterol, ψ-taraxasterol, 






oleanolic acid saponins: calenduloside A-
H[19-22],  oleanane triterpene glycoside: 
calendulaglycoside A, calendulaglycoside 
A6′-O-n-methyl ester, calendulaglycoside A6’-
O-n-butyl ester, calendulaglycoside B, 
calendulaglycoside B 6′-O-n-butyl ester, 
calendulaglycoside C, calendulaglycoside C 
6′-O-n-methyl ester, calendulaglycoside C 6′-
O-n-butyl ester, calenduloside F6′-O-n-butyl 
ester, calnduloside G6′-O-n-methyl ester[18], 
glucosides of oleanolic acid (mainly found in 
roots of grown and senescing plants) I, II, III, 
VI, VII [23,24], and glucuronides (mainly 
found in flowers and green parts) F, D, D2, C, 
B and A[25]. One new triterpenic ester of 
olanane series has been isolated from 





Various flavonoids (Table 3) have been 
isolated from the ethanol extract of the 
inflorescence of C. officinalis. They include 
quercetin, isorhamnetin[27], isoquercetin, 
isorhamnetin-3-O-β-D-glycoside, narcissin, 
calendoflaside [28], calendoflavoside, 











The ethanol extract of the inflorescence of 
the C. officinalis reported to contain 







Quinones reported from C. officinalis were 
plastoquinone, phylloquinone, α-tocopherol in 
the chloroplast, ubiquinone, phylloquinone, α-
tocopherol in mitochondria, and 




C. officinalis flowers contain maximum 
volatile oil at full flowering stage (0.97 %) and 
minimum during the preflowering stage (0.13 
%) [31]. The composition also showed 
different patterns at different phases of 
vegetative cycles. Various monoterpenes and 
sesquiterpenes have been  reported in the 
volatile oil : α-thujene, α-pienene, sabinene, 
β-pienene, limonene, 1,8-cineol, p-cymene, 
trans-β-ocimene, γ-terpenene, δ-3-carene, 
nonanal, terpene-4-ol, 3-cylohexene-1-ol, α-
phellandrene, α-terpeneol, geraniol, 
carvacrol, bornyl acetate, sabinyl acetate, α-
cubebene, α-copaene, α-bourbonene, β-
cubebene, α-gurjunene, aromadendrene, β-
caryophyllene, α-ylangene, α-humulene, epi-
bicyclo-sequiphellandrene, germacrene D, 
alloaromadendrene, β-saliene, calarene, 
muurolene, δ-cadinene, cadina 1,4-diene, α-
cadinene, nerolidol, palustron, 
endobourbonene, oplopenone, α-cadinol, T-
muurolol. The essential oil was found to be 
rich in α-cadinene, α-cadinol, t-muurolol, 
limonene, and 1,8-cineol with p-cymene at 
lower levels at the post-flowering periods 
[31]. 
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The methanol extract of leaves, petals and 
pollens of C. officinalis flowers showed a 
number of carotenoids. The carotenoids 
found in the pollens and petals were 
neoxanthin, 9Z-neoxanthin, violaxanthin, 
luteoxanthin, auroxanthin, 9Z-violaxanthin, 
flavoxanthin, mutatoxanthin, 9Z-
anthroxanthin, lutein, 9/9′A-lutein, 13/13′Z-
lutein, α-cryptoxanthin, β-cryptoxanthin, z-
cryptoxanthin, lycopene, α-carotene, and β-
carotene. Total carotenoids (mg/g dry weight) 
was 7.71 % for petals and1.61 % for pollens. 
 
Reported carotenoid compositions of the 
leaves and stems reported were neoxanthin, 
9Z-neoxanthin, violaxanthin, luteoxanthin, 9Z-
violaxanthin, 13Z-violaxanthin, anthera-
xanthin, mutatoxanthin epimer 1, 
mutatoxanthin epimer 2, lutein, 9/9′ 2-lutein, 
α-cryptoxanthin, β-cryptoxanthin, β-carotene. 
Total carotenoids (mg/g dry weight) for the 





The ethanol extract of the flowers of the plant 
is reported to show the presence of 15 amino 
acids in free form: alanine, arginine, aspartic 
acid, aspargine, valine, histidine, glutamic 
acid, leucine, lysine, proline, serine, tyrosine, 
threonine, methionine and phenylalanine. 
Amino acid content of the leaves is about 5 
%, stems 3.5 % and flowers 4.5 % [34]. 
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      Table 3: Structures and activities of some flavonoids 
 





















































































The ethanol extract of the inflorescence of 
plant showed the presence of 
polysaccharides, PS-I,-II, and -III having a 
(1→3)-β-D-galactam backbone with short 
side chains at C-6 comprising α-araban-
(1→3)-araban and alpha-L-rhamnan-(1→3)-




The lipids in the petroleum ether extract of 
the seeds, leaves and flowers of C. officinalis 
have been analyzed. The amount of neutral 
lipids in the seeds was 15.7 %, phospholipids 
0.6 % and glycolipids 0.9 %. Fatty acids of 
monols, sterol esters, 3-monoesters, 3-
monoester diols reported in flowers were 
lauric, myristic, palmitic, stearic, oleic, linoleic 
and linolenic acid. The fatty acids of marigold 
seeds contain about 59% of an 18:3 
conjugated trienic (trans-8,trans-10, cis-12) 
acid and about 5% of 9-hydroxy-18:2 (trans-
9,cis-11) acid - dimorphecolic acid [37,38] 
one oxygenated fatty acid also reported from 
the seed oil of C. officinalis was D-(+)-9-




Other phtytochemicals include the bitter 
constituent, loliolide (calendin) [40], calendulin 
[41] and n-paraffins [42]. 
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PHARMACOLOGICAL ACTIVITIES 
 
Pharmacological studies have confirmed that 
C.officinalis exhibit a broad range of 
biological effects, some of which are very 
interesting for possible future development. 
 
Anti-inflammatory and antioedematous 
activities 
 
Ethyl acetate soluble fraction of the methanol 
extract of C. officinalis flowers exhibited the 
most potent inhibition (84 %) of 12-o-
tetradecanoyl phorbol-13-acetate (TPA)-
induced inflammation (1 µg/ear) in mice with 
an ID50 value of 0.05 - 0.20 mg/ear compared 
with indomethacin as reference drug. 
Furthermore, activity-guided isolation showed 
that its activity was mainly due to oleanane-
type triterpene glycoside[18]. A dose of 1200 
µg/ear of an aqueous-ethanol extract showed 
20 % inhibition in croton oil-induced mouse 
oedema. The activity was attributed to the 
presence of triterpenoids, the three most 
active compounds of which were the esters of  
faradiol-3-myristic acid, faradiol-3-palmitic 
acid and 4-taraxasterol [43,44].  
 
Dichloromethane extract of the plant’s flower 
heads inhibited croton oil-induced oedema, 
and further isolation showed that the esters of 
faradiol-myristic acid, faradiol-palmitic acid 
and ψ-taraxasterol had antioedematous 
activity with an oedema inhibition of nearly 50 
% at a dose of 240 µg/cm
2
. Furthermore, 
when the doses of these two faradiol esters 
were doubled, oedema inhibition increased to 
65 and 66 %, respectively, without any 
synergism between them [45]. A cream 
containing calendula extract has been 
reported to be effective in dextran and burn 
oedemas as well as in acute lymphoedema in 
rats. Activity against lymphoedema was 
primarily attributed to enhancement of 




Dichloromethane-methanol (1:1) extract of C. 
officinalis flowers exhibited potent anti-HIV 
activity in in vitro MTT/tetrazolium-based 
assay. This activity was attributed to inhibition 
of HIV1-RT at a concentration of 1,000 µg 
/mL as well as suppression of the HIV-
mediated fusion at 500 µg/mL [47]. 
 
Antibacterial and antifungal activities 
 
The methanol extract and 10 % decoction of 
the plant’s flowers were assessed for their 
activity against anaerobic and facultative 
aerobic periodontal bacteria, namely, 
Porphyromonos gingivalis, Prevotella spp., 
Furobacterium nucleatum, Caphocytophaga 
gingivalis, Veilonella parvula, Eikenella 
corrodens, Peptostreptococcus micros and 
Actinomyces odontolyticus. The results 
showed marked inhibition against all tested 
microorganisms with MIC ≥2048 mg/L [48]. 
When the essential oil of the flowers was 
tested (using disc diffusion technique) against 
various fungal strains, namely, Candida 
albicans(ATCC64548), Candida dubliniensis 
(ATCC777), Candida parapsilosis 
(ATCC22019), Candida 
glabrata(ATCC90030), Candida krusei 
(ATCC6258), and yeast isolated from 
humans, viz, Candida albicans, Candida 
dubliniensis, Candida parapsilosis, Candida 
glabrata, Candida tropicalis, Candida 
guilliermondii, Candida krusei and 
Rhodotorella spp., it showed good potential 
antifungal activity (at 15 µl/disc) [49]. 
 
Anticancer and lymphocyte activation 
dual activities   
 
The ethyal acetate soluble fraction of the 
methanol extract of C. officinalis flowers has 
shown cytotoxic activity in vitro [18]. Further 
activity-guided isolation of that fraction 
showed that the active compounds were: 
calenduloside F6'-O-n-butyl ester, which is 
active against leukaemia (MOLT-4 and RPMI 
8226), colon cancer (HCC-2998) and 
melanoma (LOXIMVI, SK-MEL-5 and UACC-
62)] cell lines with GI50 values of 0.77-0.99 
µmole, except for leukaemia (CCRF-CEM, 
GI50 = 23.1 µmole), renal cancer (AK-1, 17.2 
µmole; UO-31, 12.7 µmole) and breast 
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cancer (NCI/ADR-RES, >50 µmole)] cell 
lines; and calenduloside G6'-O-methyl ester, 
which is active against all the cancer cell 
lines mentioned above with GI50≤ 20 µmole 
except for ovarian cancer (IGROVI, GI50 = 
20.1 µmole) and renal cancer (VO-31, 33.3 
µmole) cell lines[18]. Aqueous laser-activated 
calendula flower extract (LACE) showed 
potent in vitro inhibition of tumour cell 
proliferation when assayed against a wide 
variety of human and murine tumour cell 
lines. The inhibition ranged from 70 – 100 % 
with an IC50 concentration of 60 µg/mL. The 
mechanisms of the inhibition were identified 
as cell cycle arrest in G0/G1 phase and 
caspase-3 induced apoptosis. On the other 
hand, when LACE was assayed against 
human peripheral blood lymphocyte (PBLs) 
and human natural killer cell lines (NKL) it 
showed in vitro induction of proliferation and 





T lymphocytes and NKT 
lymphocyte[50]. 
 
Various extracts of the leaf, flower and whole 
plant have also been found to be cytotoxic to 
MRC5, HeP2, ascetic cells from Ehrlich 
carcinoma. The saponin rich fraction of these 
extracts displayed antitumoural activity in vivo 




The hydroalcohol extract of the flowers, when 
given to CCl4-intoxicated liver in albino male 
Wistar rats at a dose of 10 mL/kg, resulted in 
a reduction of hepatocytolysis by 28.5 % due 
to reduction in glutamo-oxalate-transaminase 
(GOT) and glutamo-pyruvate-transaminase 
(GPT). However, histoenzymology showed 
reduction of steatosis of lactate 
dehydrogenase (LDH), succinate 




triphosphatase (ATPase) [52]. The hot water 
extract of C. officinalis flowers exhibited 
antihepatoma activity against five human liver 
cancer cells - HepG2/C3A, SK-HEP-1, 
HA22T/VGH, Hep3B and PLC/PRF/5 - with 
an inhibitory effect of 25 – 26 % at a dose of 




The polysaccharide fraction of C. officinalis 
extract showed immunostimulant activity, 
based on in vitro granulocyte test. 
Polysaccharide III showed the highest 





 mg/mL, while PS-I and PS-II 
exhibited 40 – 57 and 20 – 30 % 




A 70 % methanol extract of the plant was 
successively extracted with ether, chloroform, 
ethyl acetate and n-butanol leaving a residual 
aqueous extract which was assayed for 
antioxidant activity by liposomal lipid 
peroxidation-induced Fe
2+
 and ascorbic acid. 
The ether, butanol and water extracts, 
containing flavonoids, showed antioxidant 
activity [54]. Propylene glycol extracts of the 
petals and flower heads, assayed for 
antioxidant activity by lipid peroxidation, 
indicate that the extract of the petals was 
more potent than the flower head extract, 
based on analysis of plasma and urine 
malondialdehyde (MDA) and urine 
isoprostane inventrations (ipf2α-VI)[55]. 
 
Wound healing activity 
 
The ethanol extract of the plant’s flowers was 
investigated against experimentally induced 
thermal burns in rats. Among the various 
extract doses (20, 100, and 200 mg/kg of 
body weight), the 200 mg/kg dose showed 
significant improvement in healing of wounds 
as indicated by increase in collagen-
hydroxyproline and hexosamine contents. 
The level of acute phase proteins 
(heptaglobin, orosomycid and tissue damage 
marker enzymes - alkaline phosphatase), 
alanine and aspartate transaminase 
decreased significantly. The decrease in lipid 
peroxidation might be due to its antioxidant 
property [56]. 
Muley et al 
Trop J Pharm Res, October 2009; 8 (5):  462 
 
The daily application of 2% calendula gel 
resulted in a greater number of wound 
healing due to its antimicrobial and 
antioxidant property [57]. 
 
Spasmolytic and spasmogenic dual 
activity 
 
The aqueous-ethanol extract of C. officinalis 
flowers ,when assayed in rabbit jejunum, 
caused a dose-dependant (0.03 - 3.0 mg/mL) 
relaxation of spontaneous and K
+
- induced 
contraction; further fractionation of the extract 
with dichloromethane showed inhibition of 
spontaneous contractions in a dose range of 
0.01 - 0.3 mg/mL. This is ten times more 
potent than the parent crude extract, and 
spasmolytic activity was found to be due to 
calcium channel blockade (CCB)[58]. On the 
other hand, the aqueous fraction of the 
parent extract exhibited spasmogenic activity 




The acetone: methanol (2:1 v/v) extract of the 
flowers showed insecticidal activity when it 
was tested on milkweedbug[59]. 
 
Inhibition of heart rate 
 
The aqueous extract was tested on the heart 
of male Wistar rats and found to inhibit heart 
rate contractility by up to 100 % at a dose of 
0.3mg/L [60]. 
 
Genotoxic and antigenotoxic dual 
activities 
 
The aqueous (AE), aqueous-ethanol (AEE), 
ethanol and chloroform extracts of C. 
officinalis flowers were evaluated to 
determine if they caused induction of 
unscheduled DNA synthesis (UDS) in rat liver 
culture and reversal of diethylnitrosamine 
(DEN)-induced UDS. In the UDS test in liver 
culture, DEN, at a level of 1.25 µmole, 





HdTT) incorporation while AE and 
AEE  extracts showed complete reversal of 
DEN effect at levels of around 50 ng/mL, and 
between 0.4 and 16 ng/mL, respectively. In 
the absence of DEN, these two polar extracts 
induced UDS at concentrations of 25 and 3.7 
- 100 µg /mL for AE and AEE, respectively, in 
rat liver cell culture. Thus these polar extracts 
(AE and AEE) at low concentrations (i.e., 
ng/mL range) showed antigenotoxic effect 
while at high concentrations (i.e., µg/mL 
range) they exhibited genotoxic effect [61]. 
The propylene glycol extract of C. officinalis 
also showed antigenotoxic effect based on an 
evaluation in young growing pigs which 
involved the measurement of the excretion of 






A tincture of the flowers suppressed the 
replication of herpes simplex, influenza A2 




The hydroalcohol extract of C. officinalis 
flowers,, based on assessment in rats and 
mice, did not show acute toxicity following 
administration of an oral dose of up to 5.0 
g/kg. It didn’t show haematological alterations 
at doses of 0.025, 0.25, 0.5 and 1.0 g/kg. 
However, the biochemical parameters, blood 
urea nitrogen (BUN) and alanine 
transaminase (ALT), were elevated due to 




The extract was found to cause allergy in 9 
patients out of 443 (2.03 %) when assessed 
by patch testing method[64]. Therefore, it is 
advisable that the persons who have an 
established allergy to the Asteraceae (daisy) 
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CONCLUSION 
 
In this review, we have presented information 
on the botanical description, traditional uses, 
phytochemistry and pharmacology of C. 
officinalis Linn. (Asteraceae), a medicinal 
plant found in central and southern Europe, 
western Asia and the United States, amongst 
others. A variety of phytochemicals such as 
terpenoids, flavonoids, coumarins, quinones, 
volatile oil, carotenoids and others have been 
reported to be present in this plant. It exhibits 
several pharmacological activities such anti-
HIV, anti-cancer (dual activity), anti-
inflammatory, hepatoprotective, spasmolytic 
and spasmogenic (dual activity), amongst 
others. It is potentially an important medicinal 
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